Last 12 months
Inside the activity.
0 purchase rows · 64 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 26 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 10 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 07, 2020 Filed Dec 9, 2020 16:40 UTC |
Goone David SChief Strategic Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 1,955 | $0.00 Strike: $57.31 | $0.00 |
DisclosureSEC source: 0001209191-20-062527 · doc4.xml · derivative · entry 7 Goone David S · CIK 0001343869 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,475 Underlying: Common Stock · 1,955 shares Expires 2027-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 16:40 UTC |
Goone David SChief Strategic Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 1,990 | $0.00 Strike: $50.01 | $0.00 |
DisclosureSEC source: 0001209191-20-062527 · doc4.xml · derivative · entry 6 Goone David S · CIK 0001343869 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,280 Underlying: Common Stock · 1,990 shares Expires 2026-01-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 16:40 UTC |
Goone David SChief Strategic Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 22,795 | $0.00 Strike: $41.37 | $0.00 |
DisclosureSEC source: 0001209191-20-062527 · doc4.xml · derivative · entry 5 Goone David S · CIK 0001343869 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,795 shares Expires 2024-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 16:40 UTC |
Goone David SChief Strategic Officer
|
SaleCommon Stock | 22,795 | $110.04 | $2,508,354.96 |
DisclosureSEC source: 0001209191-20-062527 · doc4.xml · nonDerivative · entry 4 Goone David S · CIK 0001343869 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,674 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $110.00 - $110.14. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 164,142 shares of common stock and 20,532 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2020 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021 and will be reported at the time of vesting. The satisfaction of the 2018, 2019 and 2020 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021, February 2022 and February 2023, respectively, and will be reported at the time of vesting. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 16:40 UTC |
Goone David SChief Strategic Officer
|
Exercise / conversionCommon Stock | 1,955 | $57.31 | $112,041.05 |
DisclosureSEC source: 0001209191-20-062527 · doc4.xml · nonDerivative · entry 3 Goone David S · CIK 0001343869 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,469 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 16:40 UTC |
Goone David SChief Strategic Officer
|
Exercise / conversionCommon Stock | 1,990 | $50.01 | $99,519.90 |
DisclosureSEC source: 0001209191-20-062527 · doc4.xml · nonDerivative · entry 2 Goone David S · CIK 0001343869 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,514 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 16:40 UTC |
Goone David SChief Strategic Officer
|
Exercise / conversionCommon Stock | 22,795 | $41.37 | $943,029.15 |
DisclosureSEC source: 0001209191-20-062527 · doc4.xml · nonDerivative · entry 1 Goone David S · CIK 0001343869 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,524 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 21:41 UTC |
Hill Scott AChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 39,800 | $0.00 Strike: $41.37 | $0.00 |
DisclosureSEC source: 0001209191-20-062529 · doc4.xml · derivative · entry 3 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 39,800 shares Expires 2024-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 21:41 UTC |
Hill Scott AChief Financial Officer
|
SaleCommon Stock | 39,800 | $110.14 | $4,383,763.04 |
DisclosureSEC source: 0001209191-20-062529 · doc4.xml · nonDerivative · entry 2 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,992 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $110.00 - $110.43. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 120,979 shares of common stock and 25,013 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2020 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021 and will be reported at the time of vesting. The satisfaction of the 2018, 2019 and 2020 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021, February 2022 and February 2023, respectively, and will be reported at the time of vesting. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 21:41 UTC |
Hill Scott AChief Financial Officer
|
Exercise / conversionCommon Stock | 39,800 | $41.37 | $1,646,526.00 |
DisclosureSEC source: 0001209191-20-062529 · doc4.xml · nonDerivative · entry 1 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,792 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| December 04, 2020 Filed Dec 8, 2020 21:47 UTC |
Mulhern Mark FDirector
|
GrantCommon Stock | 1,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-062292 · doc4.xml · nonDerivative · entry 1 Mulhern Mark F · CIK 0001342425 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,693 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. Read SEC document |
| December 04, 2020 Filed Dec 8, 2020 21:46 UTC |
Cooper Shantella E.Director
|
GrantCommon Stock | 1,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-062289 · doc4.xml · nonDerivative · entry 1 Cooper Shantella E. · CIK 0001698291 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,693 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. Read SEC document |
| November 30, 2020 Filed Dec 1, 2020 16:31 UTC |
Goone David SChief Strategic Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 17,281 | $0.00 Strike: $41.37 | $0.00 |
DisclosureSEC source: 0001209191-20-060894 · doc4.xml · derivative · entry 6 Goone David S · CIK 0001343869 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,795 Underlying: Common Stock · 17,281 shares Expires 2024-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options are fully vested. Read SEC document |
| November 30, 2020 Filed Dec 1, 2020 16:31 UTC |
Goone David SChief Strategic Officer
|
SaleCommon Stock | 17,281 | $105.05 | $1,815,305.11 |
DisclosureSEC source: 0001209191-20-060894 · doc4.xml · nonDerivative · entry 4 Goone David S · CIK 0001343869 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,729 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · price: The price range for the aggregate amount sold by the direct holder is $105.00 - $105.15. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 160,197 shares of common stock and 20,532 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2020 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021 and will be reported at the time of vesting. The satisfaction of the 2018, 2019 and 2020 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021, February 2022 and February 2023, respectively, and will be reported at the time of vesting. Read SEC document |
| November 30, 2020 Filed Dec 1, 2020 16:31 UTC |
Goone David SChief Strategic Officer
|
Exercise / conversionCommon Stock | 17,281 | $41.37 | $714,914.97 |
DisclosureSEC source: 0001209191-20-060894 · doc4.xml · nonDerivative · entry 3 Goone David S · CIK 0001343869 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,010 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| November 27, 2020 Filed Dec 1, 2020 16:31 UTC |
Goone David SChief Strategic Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 5,514 | $0.00 Strike: $41.37 | $0.00 |
DisclosureSEC source: 0001209191-20-060894 · doc4.xml · derivative · entry 5 Goone David S · CIK 0001343869 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,076 Underlying: Common Stock · 5,514 shares Expires 2024-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options are fully vested. Read SEC document |
| November 27, 2020 Filed Dec 1, 2020 16:31 UTC |
Goone David SChief Strategic Officer
|
SaleCommon Stock | 5,514 | $105.00 | $578,994.26 |
DisclosureSEC source: 0001209191-20-060894 · doc4.xml · nonDerivative · entry 2 Goone David S · CIK 0001343869 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,729 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $105.00 - $105.03. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| November 27, 2020 Filed Dec 1, 2020 16:31 UTC |
Goone David SChief Strategic Officer
|
Exercise / conversionCommon Stock | 5,514 | $41.37 | $228,114.18 |
DisclosureSEC source: 0001209191-20-060894 · doc4.xml · nonDerivative · entry 1 Goone David S · CIK 0001343869 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,243 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| November 13, 2020 Filed Nov 13, 2020 22:04 UTC |
Surdykowski Andrew JGeneral Counsel
|
GiftCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-058326 · doc4.xml · nonDerivative · entry 4 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,242 F4 · shares: This transaction involved a gift of 200 shares of the issuer's common stock by the reporting person to a philanthropic organization. F5 · balance_after: The common stock number referred in Table I is an aggregate number and represents 31,116 shares of common stock and 6,126 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2020 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021 and will be reported at the time of vesting. The satisfaction of the 2018, 2019 and 2020 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021, February 2022 and February 2023, respectively, and will be reported at the time of vesting. Read SEC document |
| November 10, 2020 Filed Nov 13, 2020 22:04 UTC |
Surdykowski Andrew JGeneral Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 4,640 | $0.00 Strike: $41.59 | $0.00 |
DisclosureSEC source: 0001209191-20-058326 · doc4.xml · derivative · entry 5 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,570 Underlying: Common Stock · 4,640 shares Expires 2025-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options are fully vested. Read SEC document |
| November 10, 2020 Filed Nov 13, 2020 22:04 UTC |
Surdykowski Andrew JGeneral Counsel
|
SaleCommon Stock | 1,070 | $97.95 | $104,801.69 |
DisclosureSEC source: 0001209191-20-058326 · doc4.xml · nonDerivative · entry 3 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,442 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · price: The price range for the aggregate amount sold by the direct holder is $97.71 - $98.21. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| November 10, 2020 Filed Nov 13, 2020 22:04 UTC |
Surdykowski Andrew JGeneral Counsel
|
SaleCommon Stock | 1,000 | $97.05 | $97,050.00 |
DisclosureSEC source: 0001209191-20-058326 · doc4.xml · nonDerivative · entry 2 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,512 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $96.70 - $97.63. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| November 10, 2020 Filed Nov 13, 2020 22:04 UTC |
Surdykowski Andrew JGeneral Counsel
|
Exercise / conversionCommon Stock | 4,640 | $41.59 | $192,977.60 |
DisclosureSEC source: 0001209191-20-058326 · doc4.xml · nonDerivative · entry 1 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,512 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 08:00 UTC |
Wassersug MarkChief Operating Officer
|
SaleCommon Stock | 1,526 | $104.56 | $159,558.56 |
DisclosureSEC source: 0001209191-20-057823 · doc4.xml · nonDerivative · entry 1 Wassersug Mark · CIK 0001722544 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,455 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 11,956 shares of common stock and 8,499 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2020 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021 and will be reported at the time of vesting. The satisfaction of the 2018, 2019 and 2020 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021, February 2022 and February 2023, respectively, and will be reported at the time of vesting. Read SEC document |
| October 08, 2020 Filed Oct 9, 2020 16:35 UTC |
Wassersug MarkChief Operating Officer
|
SaleCommon Stock | 2,946 | $101.29 | $298,400.34 |
DisclosureSEC source: 0001209191-20-054469 · doc4.xml · nonDerivative · entry 1 Wassersug Mark · CIK 0001722544 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,981 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 13,482 shares of common stock and 8,499 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2020 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021 and will be reported at the time of vesting. The satisfaction of the 2018, 2019 and 2020 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021, February 2022 and February 2023, respectively, and will be reported at the time of vesting. Read SEC document |
| September 23, 2020 Filed Sep 25, 2020 17:09 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 17,694 | $0.00 Strike: $22.50 | $0.00 |
DisclosureSEC source: 0001209191-20-052111 · doc4.xml · derivative · entry 7 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,694 shares Expires 2021-01-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: These options are fully vested. Read SEC document |
| September 23, 2020 Filed Sep 25, 2020 17:09 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 11,130 | $99.29 | $1,105,105.49 |
DisclosureSEC source: 0001209191-20-052111 · doc4.xml · nonDerivative · entry 4 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,390,946 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F4 · price: The price range for the aggregate amount sold by the direct holder is $99.03 - $99.71. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F5 · balance_after: The common stock number referred in Table I is an aggregate number and represents 1,310,680 shares of common stock and 80,266 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2020 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021 and will be reported at the time of vesting. The satisfaction of the 2018, 2019 and 2020 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021, February 2022 and February 2023, respectively, and will be reported at the time of vesting. Read SEC document |
| September 23, 2020 Filed Sep 25, 2020 17:09 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 13,561 | $98.61 | $1,337,277.33 |
DisclosureSEC source: 0001209191-20-052111 · doc4.xml · nonDerivative · entry 3 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,402,076 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · price: The price range for the aggregate amount sold by the direct holder is $98.02 - $99.01. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| September 23, 2020 Filed Sep 25, 2020 17:09 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 13,335 | $97.24 | $1,296,723.40 |
DisclosureSEC source: 0001209191-20-052111 · doc4.xml · nonDerivative · entry 2 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,415,637 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $96.85 - $97.80. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| September 23, 2020 Filed Sep 25, 2020 17:09 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 17,694 | $22.50 | $398,115.00 |
DisclosureSEC source: 0001209191-20-052111 · doc4.xml · nonDerivative · entry 1 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,428,972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| September 17, 2020 Filed Sep 21, 2020 20:37 UTC |
Silver Caroline LouiseDirector
|
GrantCommon Stock | 2,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-051290 · doc4.xml · nonDerivative · entry 1 Silver Caroline Louise · CIK 0001821735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,100 F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. Read SEC document |
| September 08, 2020 Filed Sep 10, 2020 16:25 UTC |
Wassersug MarkChief Operating Officer
|
SaleCommon Stock | 2,344 | $99.33 | $232,829.52 |
DisclosureSEC source: 0001209191-20-049961 · doc4.xml · nonDerivative · entry 1 Wassersug Mark · CIK 0001722544 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,927 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 16,428 shares of common stock and 8,499 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2020 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021 and will be reported at the time of vesting. The satisfaction of the 2018, 2019 and 2020 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021, February 2022 and February 2023, respectively, and will be reported at the time of vesting. Read SEC document |
| August 26, 2020 Filed Aug 28, 2020 20:34 UTC |
Surdykowski Andrew JGeneral Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 2,000 | $0.00 Strike: $22.50 | $0.00 |
DisclosureSEC source: 0001209191-20-048636 · doc4.xml · derivative · entry 4 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2021-01-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options are fully vested. Read SEC document |
| August 26, 2020 Filed Aug 28, 2020 20:34 UTC |
Surdykowski Andrew JGeneral Counsel
|
SaleCommon Stock | 800 | $105.15 | $84,118.00 |
DisclosureSEC source: 0001209191-20-048636 · doc4.xml · nonDerivative · entry 3 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,872 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · price: The price range for the aggregate amount sold by the direct holder is $104.99 - $105.33. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 28,746 shares of common stock and 6,126 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2020 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021 and will be reported at the time of vesting. The satisfaction of the 2018, 2019 and 2020 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021, February 2022 and February 2023, respectively, and will be reported at the time of vesting. Read SEC document |
| August 26, 2020 Filed Aug 28, 2020 20:34 UTC |
Surdykowski Andrew JGeneral Counsel
|
SaleCommon Stock | 1,200 | $104.61 | $125,537.04 |
DisclosureSEC source: 0001209191-20-048636 · doc4.xml · nonDerivative · entry 2 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,672 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $103.84 - $104.83. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| August 26, 2020 Filed Aug 28, 2020 20:34 UTC |
Surdykowski Andrew JGeneral Counsel
|
Exercise / conversionCommon Stock | 2,000 | $22.50 | $45,000.00 |
DisclosureSEC source: 0001209191-20-048636 · doc4.xml · nonDerivative · entry 1 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,872 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| August 24, 2020 Filed Aug 25, 2020 20:34 UTC |
Jackson BenjaminPresident
|
SaleCommon Stock | 1,000 | $105.00 | $105,000.00 |
DisclosureSEC source: 0001209191-20-048227 · doc4.xml · nonDerivative · entry 1 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,952 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 57,001 shares of common stock and 1,419 unvested restricted stock units ("RSUs"), and 20,532 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2020 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021 and will be reported at the time of vesting. The satisfaction of the 2018, 2019 and 2020 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021, February 2022 and February 2023, respectively, and will be reported at the time of vesting. Read SEC document |
| August 24, 2020 Filed Aug 25, 2020 20:33 UTC |
Martin Lynn CPresident, ICE Data Services
|
SaleCommon Stock | 2,500 | $105.02 | $262,538.00 |
DisclosureSEC source: 0001209191-20-048225 · doc4.xml · nonDerivative · entry 1 Martin Lynn C · CIK 0001754817 · President, ICE Data Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,518 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $105.00 - $105.02. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 16,319 shares of common stock and 11,199 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2020 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021 and will be reported at the time of vesting. The satisfaction of the 2018, 2019 and 2020 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021, February 2022 and February 2023, respectively, and will be reported at the time of vesting. Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 20:31 UTC |
Hill Scott AChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 39,800 | $0.00 Strike: $41.37 | $0.00 |
DisclosureSEC source: 0001209191-20-048396 · doc4.xml · derivative · entry 3 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,800 Underlying: Common Stock · 39,800 shares Expires 2024-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested. Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 20:31 UTC |
Hill Scott AChief Financial Officer
|
SaleCommon Stock | 39,800 | $105.36 | $4,193,156.86 |
DisclosureSEC source: 0001209191-20-048396 · doc4.xml · nonDerivative · entry 2 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,992 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $105.00 - $105.69. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 120,979 shares of common stock and 25,013 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2020 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021 and will be reported at the time of vesting. The satisfaction of the 2018, 2019 and 2020 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021, February 2022 and February 2023, respectively, and will be reported at the time of vesting. Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 20:31 UTC |
Hill Scott AChief Financial Officer
|
Exercise / conversionCommon Stock | 39,800 | $41.37 | $1,646,526.00 |
DisclosureSEC source: 0001209191-20-048396 · doc4.xml · nonDerivative · entry 1 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,792 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| August 19, 2020 Filed Aug 21, 2020 20:32 UTC |
Hill Scott AChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 1,751 | $0.00 Strike: $57.31 | $0.00 |
DisclosureSEC source: 0001209191-20-047937 · doc4.xml · derivative · entry 8 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,119 Underlying: Common Stock · 1,751 shares Expires 2027-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options are fully vested. Read SEC document |
| August 19, 2020 Filed Aug 21, 2020 20:32 UTC |
Hill Scott AChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 1,995 | $0.00 Strike: $50.01 | $0.00 |
DisclosureSEC source: 0001209191-20-047937 · doc4.xml · derivative · entry 7 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,930 Underlying: Common Stock · 1,995 shares Expires 2026-01-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options are fully vested. Read SEC document |
| August 19, 2020 Filed Aug 21, 2020 20:32 UTC |
Hill Scott AChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 2,510 | $0.00 Strike: $41.59 | $0.00 |
DisclosureSEC source: 0001209191-20-047937 · doc4.xml · derivative · entry 6 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,085 Underlying: Common Stock · 2,510 shares Expires 2025-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options are fully vested. Read SEC document |
| August 19, 2020 Filed Aug 21, 2020 20:32 UTC |
Hill Scott AChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 3,305 | $0.00 Strike: $41.37 | $0.00 |
DisclosureSEC source: 0001209191-20-047937 · doc4.xml · derivative · entry 5 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,600 Underlying: Common Stock · 3,305 shares Expires 2024-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options are fully vested. Read SEC document |
| August 19, 2020 Filed Aug 21, 2020 20:32 UTC |
Hill Scott AChief Financial Officer
|
Exercise / conversionCommon Stock | 1,751 | $57.31 | $100,349.81 |
DisclosureSEC source: 0001209191-20-047937 · doc4.xml · nonDerivative · entry 4 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,992 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The common stock number referred in Table I is an aggregate number and represents 120,979 shares of common stock and 25,013 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2020 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021 and will be reported at the time of vesting. The satisfaction of the 2018, 2019 and 2020 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021, February 2022 and February 2023, respectively, and will be reported at the time of vesting. Read SEC document |
| August 19, 2020 Filed Aug 21, 2020 20:32 UTC |
Hill Scott AChief Financial Officer
|
Exercise / conversionCommon Stock | 1,995 | $50.01 | $99,769.95 |
DisclosureSEC source: 0001209191-20-047937 · doc4.xml · nonDerivative · entry 3 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,241 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2020 Filed Aug 21, 2020 20:32 UTC |
Hill Scott AChief Financial Officer
|
Exercise / conversionCommon Stock | 2,510 | $41.59 | $104,390.90 |
DisclosureSEC source: 0001209191-20-047937 · doc4.xml · nonDerivative · entry 2 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,246 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2020 Filed Aug 21, 2020 20:32 UTC |
Hill Scott AChief Financial Officer
|
Exercise / conversionCommon Stock | 3,305 | $41.37 | $136,727.85 |
DisclosureSEC source: 0001209191-20-047937 · doc4.xml · nonDerivative · entry 1 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,736 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 20:38 UTC |
Surdykowski Andrew JGeneral Counsel
|
SaleCommon Stock | 1,000 | $104.00 | $104,000.00 |
DisclosureSEC source: 0001209191-20-047508 · doc4.xml · nonDerivative · entry 1 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,872 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: Amount of securities beneficially owned includes 136 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2020. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 28,746 shares of common stock and 6,126 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2020 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021 and will be reported at the time of vesting. The satisfaction of the 2018, 2019 and 2020 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2021, February 2022 and February 2023, respectively, and will be reported at the time of vesting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.